Cheng X, Swarna S, Robertson J, et al. Computer vision detects covert voluntary facial movements in unresponsive brain injury patients. Communications medicine. 2025;5(1):361. doi:10.1038/s43856-025-01042-y
Publications
Singh S, Gleason CE, Fang M, et al. Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors. Nature. 2025. doi:10.1038/s41586-025-09433-w
Valenstein ML, Wranik M, Lalgudi P V, et al. Structural basis for the dynamic regulation of mTORC1 by amino acids. Nature. 2025. doi:10.1038/s41586-025-09428-7
Baruch EN, Gleber-Netto FO, Nagarajan P, et al. Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy. Nature. 2025. doi:10.1038/s41586-025-09370-8
Venkadakrishnan VB, Presser A, Voss NCE, et al. Epigenetic De-repression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression. Cancer research. 2025. doi:10.1158/0008-5472.CAN-25-0636
Davis SM, Liu A, Teerlink CC, et al. Phenome-wide association study of male and female sex chromosome trisomies in 1.5 million participants of MVP, FinnGen, and UK Biobank. American journal of human genetics. 2025;112(9):2088-2101. doi:10.1016/j.ajhg.2025.07.017
Haj AK, Bendapudi PK. "Loss of function in protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank": reply. Journal of thrombosis and haemostasis : JTH. 2025;23(9):3009-3010. doi:10.1016/j.jtha.2025.05.019
Li W, Garcia-Rivera EM, Mitchell DC, et al. Highly specific intracellular ubiquitination of a small molecule. Nature chemical biology. 2025. doi:10.1038/s41589-025-02011-1
Lunavat TR, Nieland L, van de Looij SM, et al. Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunity. Molecular therapy : the journal of the American Society of Gene Therapy. 2025. doi:10.1016/j.ymthe.2025.08.028
Nuzzo PV, Rodrigues S, Ribeiro CF, et al. Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitors. Critical reviews in oncology/hematology. 2025;214:104910. doi:10.1016/j.critrevonc.2025.104910